CDKN1A and hepatocellular carcinoma: Downregulation of GCN5 inhibits HCC cell proliferation and xenograft tumour formation and reduces protein levels of the proliferation markers PCNA and AIB1, whilst increasing protein levels of the cell cycle inhibitor p21Cip1/Waf1 [76].